![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Changes in NCCN Guideline: Affecting First-Line (OncLive) View |
![]() |
NCCN Genetic/Familial Guideline Updates (V1.2023 u0026 V.1.2022) (Inherited Cancer Registry (ICARE)) View |
![]() |
First-line Immunotherapy: IMPower133 Regimen (OncLive) View |
![]() |
Next Generation Imaging (PSMA) and Introduction to Theranostics (AUAUniversity) View |
![]() |
Updates on Frontline Treatment of Ovarian Cancer Dr. Thomas Herzog (Day1) 2021 (POCR oncology) View |
![]() |
Improving Specificity of PSA Screening w/ Serum u0026 Urine Markers: Who Doesn’t Need a Prostate Biopsy (Grand Rounds in Urology) View |
![]() |
Hepatic/Biliary CA 2 I Case1: Biopsy I B: Seeding I 2: Pancreatic CA Mutation I 3: Fibrolamellar HCC (ACE_Oncology) View |
![]() |
Debate: Adjuvant therapy for resected node negative stage I NSCLC - Sometimes (HMP Education) View |
![]() |
Muscle Invasive Bladder Cancer Guidelines Review (Grand Rounds in Urology) View |
![]() |
Recognizing and Managing Side Effects of Androgen Deprivation Therapy (ADT) (Grand Rounds in Urology) View |